CAR T‐cell therapy for pancreatic cancer

Chimeric antigen receptor (CAR) T‐cell therapy utilizes genetic engineering to redirect a patient's own T cells to target cancer cells. The remarkable results in hematological malignancies prompted investigating this approach in solid tumors such as pancreatic cancer. The complex tumor microenv...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of surgical oncology Ročník 116; číslo 1; s. 63 - 74
Hlavní autoři:	DeSelm, Carl J., Tano, Zachary E., Varghese, Anna M., Adusumilli, Prasad S.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Wiley Subscription Services, Inc 01.07.2017
Témata:	adoptive cell therapy Antigens, Neoplasm - immunology Cancer surgery CAR T cells Carcinoembryonic Antigen - immunology CD24 Antigen - immunology checkpoint blockade chimeric antigen receptor Clinical Trials as Topic GPI-Linked Proteins - immunology Humans immunotherapy Immunotherapy, Adoptive Mesothelin Mucin-1 - immunology Neoplasm Proteins - immunology Pancreatic cancer Pancreatic Neoplasms - immunology Pancreatic Neoplasms - therapy Receptor, ErbB-2 - immunology Receptors, Antigen, T-Cell Receptors, Natural Killer Cell - immunology Stromal Cells - immunology T-Lymphocytes - immunology T-Lymphocytes - transplantation Transplantation Conditioning checkpoint blockade chimeric antigen receptor CAR T cells adoptive cell therapy immunotherapy
ISSN:	0022-4790, 1096-9098, 1096-9098
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!